BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026
Rhea-AI Summary
BrightSpring Health Services (NASDAQ: BTSG) will release its fourth quarter and full year 2025 financial results on February 27, 2026, before an earnings conference call scheduled for 8:30 a.m. ET the same day. A live and archived webcast and related presentation materials will be available on the company investor relations website under Events & Presentations.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, BTSG declined 3.63%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
BTSG gained 3.11% while peers were mixed: HQY (+2.10%), PRVA (+0.82%), PINC (+0.07%), WAY (-2.48%), OMCL (-0.79%). Moves do not indicate a broad sector rotation.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Oct 28 | Q3 2025 earnings | Positive | +0.1% | Reported strong Q3 2025 results and raised full-year 2025 revenue guidance. |
| Oct 20 | Secondary pricing | Neutral | +2.5% | Priced 15,000,000-share secondary by selling holders with concurrent share repurchase. |
| Oct 20 | Secondary launch | Neutral | +2.5% | Announced planned 15,000,000-share secondary and potential repurchase up to 10% or $50M. |
| Oct 20 | Prelim Q3 earnings | Positive | +2.5% | Preliminary Q3 2025 figures with higher revenue, EBITDA and increased 2025 guidance. |
| Oct 08 | Earnings date | Neutral | -0.5% | Set the release date and call time for Q3 2025 financial results. |
Recent earnings and capital markets updates have generally seen modest positive price reactions, with no large divergences.
Over recent months, BrightSpring reported strong Q3 2025 results, with higher revenue, gross profit, net income, and Adjusted EBITDA, and raised 2025 revenue guidance while reiterating EBITDA targets. The company also detailed a planned divestiture of its Community Living business expected to close in Q1 2026. In October 2025, selling stockholders completed a 15,000,000-share secondary offering alongside a company share repurchase. Prior earnings-date notices, like the October 31, 2025 Q3 release, drew only small price moves, similar in nature to today’s scheduling announcement.
Market Pulse Summary
This announcement sets the timetable for BrightSpring’s Q4 and full-year 2025 results on February 27, 2026, with an earnings call at 8:30 a.m. ET. It follows strong Q3 2025 performance, higher revenue guidance, and recent secondary-offering and repurchase activity detailed in filings and prior releases. Investors may focus on how full-year metrics compare with the previously raised 2025 guidance and on updates regarding the planned Community Living divestiture expected in Q1 2026.
AI-generated analysis. Not financial advice.
LOUISVILLE, Ky., Feb. 03, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its fourth quarter and full year 2025 financial results on Friday, February 27, 2026, prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day.
To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company’s investor relations website at https://ir.brightspringhealth.com under the “Events & Presentations” section, where related presentation materials will be posted prior to the conference call. The webcast may be accessed directly here.
About BrightSpring Health Services
BrightSpring Health Services provides complementary home- and community-based pharmacy and provider health solutions for complex populations in need of specialized and/or chronic care. Through the Company’s service lines, including pharmacy, home health care and primary care, and rehabilitation and behavioral health, we provide comprehensive and more integrated care and clinical solutions in all 50 states to over 450,000 customers, clients and patients daily. BrightSpring has consistently demonstrated strong and industry-leading quality metrics across its services lines, while improving the quality of life and health for high-need individuals and reducing overall costs to the healthcare system.
Contact
Investor Relations:
David Deuchler, CFA
Gilmartin Group LLC
ir@brightspringhealth.com
Media Contact:
Leigh White
leigh.white@brightspringhealth.com
502.630.7412